Sun S, Yu Y, Jo Y, Han JH, Xue Y, Cho M, Bae SJ, Ryu D, Park W, Ha KT, Zhuang S
However, following the March 2026 patent expiry in India, China and Canada, licensed manufacturers are now legally producing and supplying generic versions at significantly lower prices
Understanding GLP-1: What Are These Medications
Eli Lilly, the company developing the weight loss pill, plans to submit it for regulatory review in 2025 for the treatment of overweight or obesity, and in 2026 for type 2 diabetes
Remdios Foto: Pexels O mdico complementa que o desenvolvimento de um medicamento antiobesidade no termina quando se observa perda de peso
In some trials where the drug therapy was interrupted, part of the weight loss was maintained after some time, but otherwise it is important to make lifestyle improvements to maintain the weight loss, such as exercising and eating a healthier diet